Top Markets
Coin of the day
Gujarat Themis Biosyn Ltd. Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Ltd.

GUJTHEM
Rang in aandelen #13247
Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the... Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the creation of pharmaceuticals and medicinal chemicals. The firm also supplies bulk drugs via a job work model within India. Its product offerings include important compounds such as Rifamycin-S, an intermediate used in treatments for tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease. Another key product, Rifamycin-O, addresses ailments like traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Furthermore, they produce Lovastatin. Established in 1981, the company's operations are based out of Mumbai, India.
Aandeelprijs
$4.66
Marktkapitalisatie
$507.71M
Verandering (1 dag)
2.94%
Verandering (1 jaar)
8.43%
Land
IN
Handel Gujarat Themis Biosyn Ltd. (GUJTHEM)

Categorie

Dividendrendementgeschiedenis voor Gujarat Themis Biosyn Ltd. (GUJTHEM)
Het dividendrendement (TTM) van Gujarat Themis Biosyn Ltd. (aandelsymbool: GUJTHEM) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Gujarat Themis Biosyn Ltd. (GUJTHEM) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten